Related Experiment Video
Updated: Jul 9, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
Published on: November 7, 2020
Hepatitis C virus infection and outcome of renal transplantation
E Ridruejo1, A Cusumano, C Diaz
1Hepatology Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clinicas Norberto Quirno, CEMIC, Buenos Aires, Argentina. eridruejo@cemic.edu.ar
Insights
Hepatitis C virus (HCV) infection significantly reduces graft and patient survival rates in renal transplant recipients. Early identification and management of HCV are crucial for improving outcomes in kidney transplant patients.
Area of Science:
- Nephrology
- Hepatology
- Transplantation immunology
Background:
- Chronic hepatitis B (HBV) and C (HCV) viruses are prevalent in renal transplant recipients.
- The impact of HBV and HCV on graft and patient survival post-transplantation remains debated.
Purpose of the Study:
- To investigate the influence of anti-HCV status and other factors on graft and patient survival in renal transplant patients.
- To determine the independent predictors of graft and patient survival in a cohort of renal transplant recipients.
Main Methods:
- Retrospective analysis of renal transplant recipients between 1991 and 2004.
- Evaluation of factors including anti-HCV status, age, rejection episodes, and immunosuppressive therapy.
- Univariate and multivariate analyses to assess impact on graft and patient survival.
Main Results:
- Anti-HCV-positive status was associated with significantly reduced graft survival (56% vs. 75%) and patient survival (68% vs. 83%).
- Acute rejection episodes and three-drug immunosuppressive therapy also diminished graft survival.
- Advanced age, cadaveric donor, kidney-pancreas transplantation, and three-drug immunosuppressive therapy were linked to reduced patient survival.
Conclusions:
- Hepatitis C virus infection is a significant negative prognostic factor for both graft and patient survival after renal transplantation.
- Minimizing immunosuppression and managing acute rejection are critical for improving outcomes in HCV-positive renal transplant recipients.
Abstract:
Chronic hepatitis B and C viruses (HBV and HCV) are common problems in renal transplant patients. There is no uniform agreement regarding their influence on graft outcomes and patient survival. We evaluated the influence of anti-HCV and hepatitis B surface antigen-positive status; gender; age>49 years at the time of transplantation; alanine aminotransferase elevation; acute rejection; type of graft; number of transplants; and maintenance/induction immunosuppressive treatment on both graft and patient survivals among a population transplanted in our center between 1991 and 2004. Univariate analysis showed that anti-HCV-positive status, three-drug immunosuppressive therapy, and one or more episodes of acute rejection were associated with diminished graft survival. Over the age of 49 years at the time of transplantation, anti-HCV-positive status, cadaveric donor, kidney-pancreas transplantation, and three-drug immunosuppressive therapy were associated with diminished patient survival. Upon multivariate analysis, reduced patient survival was associated with the same variables as in the univariate analysis: anti-HCV-positive status, three-drug immunosuppressive therapy, and one or more episodes of acute rejection were associated with diminished graft survival. In our experience, anti-HCV-positive compared with anti-HCV-negative status was associated with a reduced graft (56% vs. 75%; P=.0002) and patient survival (68% vs. 83%; P=.0028).
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Hepatitis
Kidney Transplant I: Introduction
Cytomegalovirus Disease
Kidney Transplant III: Nursing Management
